cor2ed
engage checkpoint medical linkedin twitter
bg

Skin toxicity related to targeted therapy: interactive e-learning.

Skin toxicity related to targeted therapy: interactive e-learning.

Natasha Pinheiro, Dr. Nicole R. LeBoeuf, Dr. Victor Hugo Fonseca de Jesus, Dr. Catherine Frenette

An interactive e-learning on skin toxicity related to targeted therapy in GI and liver cancers

Portrait of Natasha Pinheiro
Natasha Pinheiro

Nurse Practitioner

Memorial Sloan Kettering Cancer Center

United States (US)

Portrait of Nicole R. LeBoeuf
Dr. Nicole R. LeBoeuf

Dermatologist

Brigham and Women's Hospital

United States (US)

Portrait of Victor Hugo Fonseca de Jesus
Dr. Victor Hugo Fonseca de Jesus

Medical Oncologist

A.C. Camargo Cancer Center

Brazil

Portrait of Catherine Frenette
Dr. Catherine Frenette

Gastroenterologist and Hepatologist

Scripps Clinic Center for Organ and Cell Transplantation

United States (US)

preview next

time E-learning | open 60 min |accreditation: ACCME | Sep 2020

temporal

I agree that this educational programme:

This e-learning will help nurses and physicians alike better understand skin reactions to targeted therapy in GI and liver cancers. The course aims to support the prevention, diagnosis and management of these dermatologic adverse events and encourages a multidisciplinary team approach to optimise patient care.

 

Find out more about the programme in the short video, and start your learning journey now:

  • Download an educational slide deck to capture the key content
  • Obtain your own copy of our helpful leaflet to give to your patients
  • Follow the link above to access the accredited e-learning

 

Targeted therapies lead to more dermatologic adverse events than are seen with non-targeted therapies. Skin toxicity may lead to changes in dosing, physical and psychological discomfort or pain, therefore increasing the risk of total treatment interruption, potentially leading to exacerbation of the patient’s cancer. Pre-emptively addressing and treating these potential skin toxicities may improve the quality of life for the patient and allow them to continue on therapy longer. A multidisciplinary team effort amongst healthcare professionals in the prevention, diagnosis, and management of skin toxicities associated with targeted therapy in liver and GI cancers, including hepatocellular carcinoma, colorectal cancer, pancreatic cancer, neuroendocrine tumours, gastric cancer and GIST is widely recommended as a best practice approach.

 

A number of recognised CME credits are available after completing this e-learning course. The e-learning is accredited for European CME Credits (ECMECs) and certified for AMA PRA Category 1 CreditsTM as well as American Board of Internal Medicine (ABIM) MOC credit.

Supported by:

Planned and implemented in accordance with the requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME)

GI NURSES CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Eisai Europe Limited.

Other programmes of interest

Other programmes developed by Natasha Pinheiro

Other programmes developed by Dr. Nicole R. LeBoeuf

Other programmes developed by Dr. Victor Hugo Fonseca de Jesus

Other programmes developed by Dr. Catherine Frenette